—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Incyte Corporation (INCY) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +2.4% vs the 50-day and +13.4% vs the 200-day average, 7.4% below the 52-week high and +37.6% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Incyte Corporation trades 2.4% above its 50-day and 13.4% above its 200-day moving average. (as of 2026-11-04)

Incyte develops and sells prescription medicines for blood cancers, certain solid tumours and inflammatory skin conditions, marketed mainly in the United States, Europe, Canada and Japan. Its lead product, Jakafi, treats myelofibrosis, polycythemia vera and a form of graft-versus-host disease, while other approved drugs address leukaemia, lymphoma and rare cancers.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the INCY overview. Research diary readings, not advice.

Uptrend stack intact

Trades +2.4% vs the 50-day and +13.4% vs the 200-day average, 7.4% below the 52-week high and +37.6% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the INCY chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on INCY?

Uptrend stack intact — Trades +2.4% vs the 50-day and +13.4% vs the 200-day average, 7.4% below the 52-week high and +37.6% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is INCY above its 50-day and 200-day moving averages?

As of 2026-11-04, Incyte Corporation trades +2.4% above its 50-day and +13.4% above its 200-day average, with the 20-day +6.6% away.

How far is INCY from its 52-week high?

7.4% below the 52-week high and 37.6% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.